Company news
Ocumetics Technology Corp news in 2025
Ocumetics Technology Corp's news releases, calls and decks from 2025, newest first.
Ocumetics Technology Announces Amendment to Brokered LIFE Offering Led by Centurion One Capital
December 19, 2025
Ocumetics Announces Optimized Lens Delivery System in Collaboration with Medicel
December 9, 2025
Ocumetics Technology Announces $2.5 Million Brokered LIFE Offering Led by Centurion One Capital
November 25, 2025
Ocumetics Reports Continued Improvement in First Group of Patients. Early Vision Results Surpass Expectations
November 5, 2025
Ocumetics to Present at the Centurion One Capital 3rd Annual Bahamas Summit
October 24, 2025
Ocumetics To Participate in the 2025 Maxim Growth Summit
October 21, 2025
Ocumetics Announces Issuance of Stock Options
October 15, 2025
Ocumetics Webinar - Discussion of One-Month Postoperative Patient Results
October 14, 2025
Ocumetics Reports Encouraging One-Month Postoperative Results
October 8, 2025
Ocumetics Reports Second Successful Surgery Day
September 26, 2025
Ocumetics Completes One-Month Postoperative Examinations - Results Pending
September 16, 2025
Ocumetics Engages The Howard Group to Direct Capital Market & Corporate Digital Communications Programs
September 12, 2025
Ocumetics Webinar - Accommodating Intraocular Lens Update
August 27, 2025
Ocumetics Prepares for a Second Day of Accommodating Intraocular Lens Implantations
August 26, 2025
Ocumetics Achieves Historic First: Accommodating Intraocular Lens Successfully Implanted in Human Patients
August 18, 2025
Ocumetics Achieves Clinical Milestones; Poised for Value-Defining First-in-Human Lens Implantations
August 12, 2025
Ocumetics Begins Patient Recruitment for First-In-Human Clinical Study of Accommodating Intraocular Lens
August 5, 2025
Ocumetics Receives Ethics Committee Approval for First-In-Human Clinical Study of Accommodating Intraocular Lens
July 30, 2025
Ocumetics Announces Completion of First Tranche of Unit Private Placement
July 17, 2025
Ocumetics Completes Staff Training for First-In-Human Clinical Study of Accommodating Intraocular Lens
July 9, 2025
Ocumetics Completes Virtual Site Initiation for First-In-Human Clinical Study of Accommodating Intraocular Lens
June 26, 2025
First-In-Human Study of Accommodating Intraocular Lens Set to Begin June 26, 2025
June 24, 2025
Ocumetics Announces Private Placement
June 4, 2025
Ocumetics Targets June 26, 2025 for Commencement of its First in Human Study
June 3, 2025
Ocumetics Announces Mexico City as Site for its First in Human Study
June 2, 2025
Ocumetics Clinical Study Protocol Submission and Site Initiation on Schedule for Summer 2025
May 22, 2025
Ocumetics Completes Manufacturing of Lenses to be used in First-in-Human Study
May 14, 2025
Ocumetics Announces Lens Design Freeze for First-in-Human Study
May 12, 2025
Ocumetics Achieves Key Milestone: Laboratory Testing Confirms Accommodative Power Target was Successfully Achieved in Preparation for First-in-Human Trials
May 8, 2025
Ocumetics Announces Corporate Changes
May 1, 2025
Ocumetics Announces Completion of Major Milestones First-In-Human Surgery Planned for Summer 2025
April 22, 2025
Ocumetics Engages Independent Trading Group as Market Maker
March 24, 2025
Ocumetics Announces Appointment of Michael L. Edwards to Board of Directors
March 11, 2025
Ocumetics Announces Issuance of Restricted Share Units
January 24, 2025
Decks in 2025
- Investor Presentation (November 2025)
Investor deck · 36 slides · November 2025
- Investor Presentation (November 2025)
Investor deck · 19 slides · November 2025
- Investor Presentation (June 2025)
Investor deck · 36 slides · June 2025
- Investor Presentation (March 2025)
Investor deck · 36 slides · March 2025